Skip to main content
Top
Published in: The Journal of Obstetrics and Gynecology of India 1/2016

01-10-2016 | Original Article

Role of Tranexamic Acid in Reducing Blood Loss in Vaginal Delivery

Authors: Priyankur Roy, M. S. Sujatha, Ambarisha Bhandiwad, Bivas Biswas

Published in: The Journal of Obstetrics and Gynecology of India | Special Issue 1/2016

Login to get access

Abstract

Introduction

Anti-fibrinolytic agents are used to reduce obstetric blood loss as the fibrinolytic system is known to get activated after placental delivery.

Objectives

To evaluate the efficacy of parenteral tranexamic acid in reducing blood loss during normal labour and to compare it with the amount of blood loss in patients who received placebo in the third stage of labour.

Methodology

Patients with spontaneous labour or planned for induction of labour and fulfilling the inclusion criteria were recruited for the study. In each patient, the pre-delivery pulse rate, blood pressure, Hb gm% and PCV% were noted. Labour was monitored carefully using a partogram. The study group received Inj. Oxytocin and Inj. Tranexamic acid. The control group received Inj. Oxytocin and Placebo injection. Immediately after delivery of the baby, when all the liquor was drained, the patient was placed over a blood drape—a disposable conical, graduated plastic collection bag. The amount of blood collected in the blood drape was measured. Then the patient was given pre-weighed pads, which were weighed 2 h post-partum. The blood loss was measured by measuring the blood collected in the drape and by weighing the swabs before and after delivery.

Results

The total number of patients studied was 100—equally distributed in both the groups. The age group of the patients and BMI were comparable. There was a significant increase in the pulse rate and decrease in blood pressure in the control group as compared with the study group. The post-delivery haemoglobin and haematocrit were significantly reduced in the control group as compared to the study group. The mean blood loss at the end of 2 h was 105 ml in the study group and 252 ml in the control group. There was a significant increase in the usage of uterotonics and also in the need for blood transfusion in the control group; 12 % of the patients in the control group had to stay for more than 3 days compared to 2 % in the study group.

Conclusion

Tranexamic acid injection, an antifibrinolytic agent when given prophylactically after the delivery of the baby, by intravenous route appears to reduce the blood loss and maternal morbidity during normal labour effectively.
Literature
1.
go back to reference Henry DA, Carless PA, Moxey AJ et al. Antifibrinolytic use for minimizing perioperative allogenic blood transfusion. Cochrane Database Syst Rev. 2007; Issue 4. Art No: CD001886. Henry DA, Carless PA, Moxey AJ et al. Antifibrinolytic use for minimizing perioperative allogenic blood transfusion. Cochrane Database Syst Rev. 2007; Issue 4. Art No: CD001886.
2.
go back to reference Lethaby A, Farquhar C. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000; Issue 4. Art No: CD000249. Lethaby A, Farquhar C. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000; Issue 4. Art No: CD000249.
3.
go back to reference Mac Mullen NJ, Dulski LA, Meagher B. MCN Am J. 2005;30:40–51. Mac Mullen NJ, Dulski LA, Meagher B. MCN Am J. 2005;30:40–51.
4.
go back to reference Gai MY, Wu LF, Su QF, et al. Clinical observation of blood loss reduced by tranexamic acid during and after caesarean section: a multi center randomized trial. Eur J Obstet Gynaecol Reprod Biol. 2004;112(2):154–7.CrossRef Gai MY, Wu LF, Su QF, et al. Clinical observation of blood loss reduced by tranexamic acid during and after caesarean section: a multi center randomized trial. Eur J Obstet Gynaecol Reprod Biol. 2004;112(2):154–7.CrossRef
5.
go back to reference Pattinson RC. Saving mothers—third report on confidential enquiries into maternal deaths in South Africa 2002–04 Pretoria, S.Africa. Pretoria: Department of Health; 2006. Pattinson RC. Saving mothers—third report on confidential enquiries into maternal deaths in South Africa 2002–04 Pretoria, S.Africa. Pretoria: Department of Health; 2006.
6.
go back to reference As AK, Hagen P, Webb JB. Tranexamic acid in management of PPH. Br J Obstet Gynaecol. 1996;103(12):1250–1.CrossRefPubMed As AK, Hagen P, Webb JB. Tranexamic acid in management of PPH. Br J Obstet Gynaecol. 1996;103(12):1250–1.CrossRefPubMed
7.
go back to reference Yang H, Zheng S, Shi C. Clinical study on the efficiency of tranexamic acid in reducing postpartum blood loss—a randomized multicentre trial. Zhonghua Fu Chan Zazhi. 2001;36(10):590–2. Yang H, Zheng S, Shi C. Clinical study on the efficiency of tranexamic acid in reducing postpartum blood loss—a randomized multicentre trial. Zhonghua Fu Chan Zazhi. 2001;36(10):590–2.
8.
go back to reference Peitsidis P, Kadir RA. Tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother. 2011;12(4):503–16.CrossRefPubMed Peitsidis P, Kadir RA. Tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother. 2011;12(4):503–16.CrossRefPubMed
9.
go back to reference Leduc D, Senikas V. Active management of third stage of labour: prevention and treatment of PPH. J Obstet Gynaecol Can. 2009;31(10):980–93.CrossRefPubMed Leduc D, Senikas V. Active management of third stage of labour: prevention and treatment of PPH. J Obstet Gynaecol Can. 2009;31(10):980–93.CrossRefPubMed
10.
go back to reference Novikova N, Hofmeyr GJ. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2010;(7):CD007872. Novikova N, Hofmeyr GJ. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2010;(7):CD007872.
11.
go back to reference Soltani H, Hutchon DR. Timing of prophylactic uterotonics for third stage of labour after vaginal birth. Cochrane Database Syst Rev. 2010; 4(8): CD006173. Soltani H, Hutchon DR. Timing of prophylactic uterotonics for third stage of labour after vaginal birth. Cochrane Database Syst Rev. 2010; 4(8): CD006173.
12.
go back to reference Tesseir V, Pierre F. Risk of PPH during labour and clinical and pharmacological prevention. J Obstet Gynaecol. 2004;33:4529–56. Tesseir V, Pierre F. Risk of PPH during labour and clinical and pharmacological prevention. J Obstet Gynaecol. 2004;33:4529–56.
13.
go back to reference Sekhavat L, Tabatabaii A. Efficacy of tranexamic acid in reducing blood loss after caesarean section. J Matern Fetal Neonatal Med. 2009;22(1):72–5.CrossRefPubMed Sekhavat L, Tabatabaii A. Efficacy of tranexamic acid in reducing blood loss after caesarean section. J Matern Fetal Neonatal Med. 2009;22(1):72–5.CrossRefPubMed
14.
go back to reference Litch JA. Program for appropriate technology and health. Seattle: AMTSL; 2004. p. 132. Litch JA. Program for appropriate technology and health. Seattle: AMTSL; 2004. p. 132.
15.
go back to reference Gokhan. Routine practice of using tranexamic acid in AMTSL. NCT01338454, Bakirkoy; 2011. Gokhan. Routine practice of using tranexamic acid in AMTSL. NCT01338454, Bakirkoy; 2011.
16.
go back to reference La Londe A, Daviss BA. PPH today: ICM/FIGO initiative 2004–2006. Int J Obstet Gynaecol. 2006;94:243–53.CrossRef La Londe A, Daviss BA. PPH today: ICM/FIGO initiative 2004–2006. Int J Obstet Gynaecol. 2006;94:243–53.CrossRef
17.
go back to reference Astedt B. Clinical pharmacology of tranexamic acid. Scand J Gastroenterol. 1987;137:22–5.CrossRef Astedt B. Clinical pharmacology of tranexamic acid. Scand J Gastroenterol. 1987;137:22–5.CrossRef
Metadata
Title
Role of Tranexamic Acid in Reducing Blood Loss in Vaginal Delivery
Authors
Priyankur Roy
M. S. Sujatha
Ambarisha Bhandiwad
Bivas Biswas
Publication date
01-10-2016
Publisher
Springer India
Published in
The Journal of Obstetrics and Gynecology of India / Issue Special Issue 1/2016
Print ISSN: 0971-9202
Electronic ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-016-0856-4

Other articles of this Special Issue 1/2016

The Journal of Obstetrics and Gynecology of India 1/2016 Go to the issue